arginyl-glycyl-aspartic acid has been researched along with zinc oxide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, W; Engle, JW; Hong, H; Nickles, RJ; Shi, J; Wang, X; Yang, Y; Zhang, Y | 1 |
| Abuelela, AF; Bharath, AA; Chen, S; Douglas, T; Greenwood, C; Merzaban, JS; Othman, BA; Porter, AE; Ryan, M; Theodorou, I; Uchida, M | 1 |
| Cai, X; Li, A; Wang, J; Yang, X; Zhang, C | 1 |
3 other study(ies) available for arginyl-glycyl-aspartic acid and zinc oxide
| Article | Year |
|---|---|
Cancer-targeted optical imaging with fluorescent zinc oxide nanowires.
Topics: Biocompatible Materials; Cell Line, Tumor; Humans; Integrin alphaVbeta3; Metal Nanoparticles; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Models, Chemical; Nanowires; Neoplasms; Oligopeptides; Optics and Photonics; Solubility; Zinc Oxide | 2011 |
Correlative Light-Electron Microscopy Shows RGD-Targeted ZnO Nanoparticles Dissolve in the Intracellular Environment of Triple Negative Breast Cancer Cells and Cause Apoptosis with Intratumor Heterogeneity.
Topics: Apoptosis; Cell Death; Cell Line, Tumor; Genetic Heterogeneity; Humans; Light; MCF-7 Cells; Metal Nanoparticles; Microscopy, Electron; Oligopeptides; Triple Negative Breast Neoplasms; Zinc Oxide | 2016 |
Red fluorescent ZnO nanoparticle grafted with polyglycerol and conjugated RGD peptide as drug delivery vehicles for efficient target cancer therapy.
Topics: Cell Line, Tumor; Colloids; Drug Delivery Systems; Glycerol; HeLa Cells; Human Umbilical Vein Endothelial Cells; Humans; Nanoparticles; Oligopeptides; Polymers; Zinc Oxide | 2019 |